-
- Mar 13/26
Lessons from bringing a novel T cell class for autoimmune diseases into the clinic - Mar 12/26
ISSCR launches education program on stem cell treatments for Parkinson’s - Mar 12/26
Cas9 protein topical treatment blocks corneal neovascularization - Mar 12/26
Allowing stem cells space to thrive - Mar 12/26
Scientists pioneer safe method for inserting gene-sized DNA into genomes - Mar 11/26
INSTALL makes non-viral gene insertion work in vivo - Mar 11/26
Dynamic gel enhances reliability of lab-grown organs for scientists - Mar 10/26
From sci-fi to reality: four futuristic advancements in biomaterials science - Mar 10/26
Gene therapy Beqvez sustains gains in 6-year hemophilia B study - Mar 10/26
Gene therapy restores vision in LRAT rat model - Mar 10/26
Chemistry student uses machine learning to transform gene therapy production - Mar 10/26
Boosting bioengineered materials with gas technology to enhance wound healing - Mar 10/26
Scientists discover key regulator of retinal progenitor cell identity - Mar 9/26
Researchers highlight ‘regenerative healing’ as a framework for health innovation - Mar 9/26
Predicting CAR T-cell therapy success in blood cancers - Mar 8/26
Weekly reads: support brain tumor work, Prasad is out (again), genetic conditions, Texas AG, immunotherapy paper, SCBEM - Mar 7/26
Efficient production of human spinal GABAergic progenitors - Mar 6/26
Ketone body can strengthen the fitness and antitumour activity of CAR T cells - Mar 6/26
Circular RNA platform boosts gene therapy expression - Mar 6/26
Prosthetics a thing of the past? How axolotls are teaching us to regrow limbs - Mar 5/26
Peptide-DNA conjugates could unlock nonviral gene therapies, researchers say - Mar 5/26
Cloaked stem cells evade immune rejection in mice, pointing to a potential universal donor cell line - Mar 5/26
Parkin gene therapy rescues dopaminergic neurons in vivo - Mar 4/26
Bayer tosses 1 Pompe gene therapy from $2B AskBio buyout to focus on alternative option - Mar 4/26
UCLA scientists develop CAR-T cells to combat challenging solid tumours - Mar 4/26
Longeveron’s laromestrocel for frailty: Breaking down cell stem cell data & problematic nature coverage - Mar 4/26
Engineering AAV capsid T cell targets in mice - Mar 4/26
Human baby teeth stem cells show potential in treating cerebral palsy - Mar 3/26
Making immunotherapy safer and more accessible through continuous digital monitoring - Mar 3/26
New therapy combines imaging and targeted radiation to treat aggressive bone cancer - Mar 3/26
FDA details rationale for rejecting rare disease gene therapy from Regenxbio - Mar 3/26
Cracking a ‘holy grail’ challenge in cancer cell therapy - Mar 3/26
Could hydrogels be the future of bone implants? - Mar 2/26
Bioprinting muscle with perfect cell alignment, mirroring human tissue - Mar 2/26
FDA tells uniQure to conduct another study of Huntington’s gene therapy - Mar 2/26
$24M verdict against Seattle Stem Cell Center clinic in man’s death - Mar 1/26
Ultrasound-guided left heart injection boosts aortic gene delivery - Mar 1/26
Weekly reads: longevity hype vs. cool research, losing your Y, FDA maelstrom - Feb 28/26
Offering fresh hope: Game-changing drug discoveries for rare disease - Feb 28/26
Dual receptor knockout boosts CAR T solid tumour therapy - Feb 27/26
Groundbreaking study finds in-utero stem cell therapy safe for fetal spina bifida repair - Feb 27/26
Rare disease developers applaud clarity in FDA guidance - Feb 27/26
U of T Entrepreneurship Week: 10 startups to watch in 2026 - Feb 21/26
Japan Approves World’s First iPS Therapies for Parkinson’s, Heart Failure - Feb 20/26
Key regulators of aging in male stem cells revealed - Feb 19/26
Japan panel approves world’s first iPS cell-based therapies - Feb 19/26
CGT Catapult establishes Technology Advisory Board to identify opportunities for the advanced therapies sector to deploy and benefit from innovations - Feb 19/26
Engineered CD4 CAR T cells reduce amyloid plaques in Alzheimer’s - Feb 19/26
“‘Cyborg’ pancreatic organoids revolutionize monitoring of islet cell maturation” - Feb 19/26
Next-generation bioelectronics interface with living ‘mini brains’ - Feb 19/26
Comprehensive bone marrow cell atlas advances leukemia research - Feb 19/26
Innovative vascularized tissueoid-on-a-chip model advances liver regeneration and transplant rejection research - Feb 18/26
Axol Bioscience acquires Newcells Biotech ophthalmology unit - Feb 18/26
Novel implant delivers tiny growth-promoting particles directly to injured nerve cells - Feb 18/26
Scaling up macrophage production with bioreactors - Feb 18/26
Michigan man gets new Roctavian gene therapy for hemophilia A - Feb 17/26
ExCellThera and Cordex Biologics’ Zemcelpro receives NUB programme status 1 in Germany - Feb 17/26
New Lund model aims to shorten the path to life-saving cell and gene therapies - Feb 17/26
Boehringer axes inhaled gene therapy after viewing cystic fibrosis data - Feb 17/26
A breakthrough discovery could help lungs repair themselves - Feb 16/26
MEDIPOST files IND amendment to FDA for Phase III osteoarthritis trial - Feb 15/26
Weekly reads: The Atlantic stem cell advertorial, Ozempic & cartilage restoration surprise, dwarfism tx - Feb 13/26
Global trends shape progress in cell and gene therapies - Feb 13/26
35 years of progress in cell and gene therapy - Feb 12/26
The role of AI in optimizing stem cell therapy for patients - Feb 12/26
UMass Chan licenses gene therapy for rare genetic disorder to Raiden Science Foundation - Feb 12/26
Unveiling AAV8’s complex degradation pathways - Feb 11/26
Early findings from first human study of in vivo CAR T in myeloma - Feb 11/26
FDA OKs risky, pioneering OSK rejuvenation trial with Sinclair’s ER-100 - Feb 10/26
Working group members appointed to the global workforce development in stem cell research and regenerative medicine initiative - Feb 10/26
Capsida confirms cause of death in clinical trial fatality for rare genetic disorder - Feb 10/26
REGENXBIO’s Hunter syndrome gene therapy fails to win FDA nod - Feb 9/26
Explainable AI reveals type 2 diabetes traits - Feb 9/26
First in-human study finds novel immune cell therapy is safe and effective in advanced lymphoma - Feb 9/26
Dana-Farber research advances lead to FDA label update for primary CNS lymphoma - Feb 9/26
Eli Lilly expands its in vivo ambitions, acquiring cell therapy startup Orna for up to $2.4B - Feb 9/26
Editing risk: Gene targets for lifelong cardiovascular disease prevention - Feb 9/26
Liver toxicities force pause on two dose groups of UniQure’s mid-stage Fabry study - Feb 8/26
Weekly reads: surprise Casgevy challenge, India bars stem cells for autism, Dorothy Bishop PubPeer analysis - Feb 7/26
Water pressure mechanism enables fast amoeboid cancer cell movement - Feb 6/26
Novel gene editing technique targets tumours overloaded with oncogenes - Feb 6/26
CAR T promises longer relief for myasthenia gravis - Feb 6/26
EAHAD 2026: Nine-year outcomes of gene therapy - Feb 6/26
New NK cell immune therapy targets hidden HIV reservoirs - Feb 5/26
Vertex sickle cell gene therapy stumbles due to slow blood cell collection from patients - Feb 5/26
Stem cell implants aim to restore dopamine in Parkinson’s disease - Feb 5/26
Human ILC1 cells fight leukemia stem growth - Feb 4/26
Could these two genes unleash the full power of T cells? - Feb 4/26
Wyoming stem cell bill is latest risky, anti-FDA state legislation - Feb 4/26
Two harmful variants can restore protein function - Feb 4/26
Enhancing ssDNA templates for CRISPR gene editing - Feb 3/26
UCLA scientists identify optimal design for off-the-shelf immunotherapy targeting solid tumours - Feb 3/26
George Coukos appointed director of new Ludwig Laboratory for Cell Therapy - Feb 2/26
5 critical challenges that biotech startups face in Canada - Feb 2/26
Inflammation ‘off-switch’ allows healing, prevents harmful immune response - Feb 2/26
Scientists identify key molecular trigger behind failed healing of certain broken bones - Feb 1/26
Creating bioactive human adipose matrix with CO2 - Feb 1/26
Weekly reads: human SCBEM framework, reporter self-injects peptides, ASD, NAMs - Feb 1/26
Lentiviral vectors revolutionize gene therapy techniques - Jan 30/26
Heart cells can regenerate, up to a point - Jan 30/26
Mesenchymal stem cells ease cerebral malaria via Tr17 - Jan 30/26
New CRISPR-based gene-editing treatment targets root cause of kidney disease - Jan 29/26
Engineered exosomes: A breakthrough in osteoporosis treatment
- Mar 13/26
